Combination of Imatinib with CXCR4 Antagonist BKT140...

Molecular Cancer Therapeutics 2014 / 05 Vol. 13; Iss. 5

Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo

Beider, K., Darash-Yahana, M., Blaier, O., Koren-Michowitz, M., Abraham, M., Wald, H., Wald, O., Galun, E., Eizenberg, O., Peled, A., Nagler, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-13-0410
Date:
May, 2014
File:
PDF, 2.22 MB
english, 2014
Conversion to is in progress
Conversion to is failed